| 释义 |
BRILLIANT II BRILLIANT II A trial which was to test the clinical performance of the batimastat-loaded stent relative to a PC Technology™ stent without the drug, and to be conducted at centres in the UK, France, Belgium and Holland. Review of the data from BRILLIANT I did not show the benefit that was evident in the pre-clinical studies, and led to suspension of patient recruitment for BRILLIANT II. |